21
We further questioned CCS if it was normal when dealing with what is, effectively, a...
Conclusion
We further questioned CCS if it was normal when dealing with what is, effectively, a financial product, to end up with only one supplier, with no resilience built in. CCS told us that it does not like putting single suppliers on a framework, but it was its engagement with the marketplace that meant that on this occasion, it made sense for it to be a single- supplier framework. CCS stated that market intelligence had suggested that, because of the thin margins, splitting the agreement into two suppliers would likely lead to no market to award the contract to.22
Government Response
A response document is linked to this report, dated 28 April 2022. Response attribution to this conclusion has not been verified. Read the response document.
Source
Committee
Public Accounts Committee
Inquiry
NHS supply chain finance
Report
Thirty-Fifth Report - The pharmacy early payment and salary advance schemes in the NHS
04 Feb 2022
HC 745
Addressee Bodies
HM Treasury
Timeline
Recommendation age
4.6 yrs
Report published
04 Feb 2022